You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment

 

Online download statistics by month:

Online download statistics by month: June 2020 to February 2026

AbstractFullPdf
Jun 2020324324164
Jul 202020620688
Aug 2020686834
Sep 202012012040
Oct 202011311348
Nov 2020969626
Dec 202011011036
Jan 202115315368
Feb 202115715731
Mar 202123423466
Apr 202116216247
May 202116216273
Jun 202116416461
Jul 202113513551
Aug 202113213259
Sep 202111511558
Oct 202112012067
Nov 202113713652
Dec 202111812138
Jan 202210911449
Feb 202211712049
Mar 202215015758
Apr 202211211942
May 2022909445
Jun 20229910034
Jul 2022626730
Aug 2022838640
Sep 20227982156
Oct 2022747417
Nov 2022485161
Dec 2022717226
Jan 2023666725
Feb 202312912945
Mar 2023828346
Apr 2023515119
May 2023565628
Jun 2023575720
Jul 2023444426
Aug 2023393817
Sep 2023757533
Oct 2023787819
Nov 2023727224
Dec 202312012025
Jan 2024616254
Feb 2024636325
Mar 20249496116
Apr 2024848556
May 2024909836
Jun 2024788038
Jul 2024768023
Aug 2024707141
Sep 2024434324
Oct 2024484932
Nov 2024545630
Dec 2024676722
Jan 2025848439
Feb 202514514529
Mar 202511011154
Apr 202511511748
May 202510810950
Jun 2025888824
Jul 2025110
Feb 2026110
Total626963402782